Ocumension Therapeutics soars 152% in HK market debut

Ocumension Therapeutics soars 152% in HK market debut

Shanghai-headquartered ophthalmology-focused pharma firm Ocumension Therapeutics on Tuesday made a stellar trading debut on the Hong Kong stock exchange with its shares soaring 152 per cent to reach a peak of HK$42.50 ($5.5) before closing at HK$38.20 ($4.9).

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter